"TASMULINE DFZ: Effective BPH and Inflammation Relief"

May 24, 2024

TASMULINE DFZ 

Tamsulosin Hydrochloride 0.4 mg PR & Deflazacort 30 mg

Introduction

Tamsulosin Hydrochloride 0.4 mg PR and Deflazacort 30 mg, combined as TASMULINE DFZ, provide a unique and effective treatment option for managing both benign prostatic hyperplasia (BPH) and inflammatory conditions. This dual-action medication addresses urinary symptoms and inflammation, offering comprehensive relief.

Uses

  • Benign Prostatic Hyperplasia (BPH): TASMULINE DFZ helps in managing the urinary symptoms associated with BPH, such as difficulty urinating, weak urine stream, and frequent urination.
  • Inflammatory Conditions: Deflazacort is a corticosteroid that helps reduce inflammation and manage autoimmune conditions, providing relief from various inflammatory symptoms.

Mechanism of Action

  • Tamsulosin Hydrochloride: An alpha-1 adrenergic antagonist that relaxes the muscles in the prostate and bladder neck, making it easier to urinate.
  • Deflazacort: A corticosteroid that reduces inflammation by inhibiting multiple inflammatory cytokines and suppressing the immune system, providing relief from inflammation and allergic reactions.

Dosage and Administration

  • Recommended Dose: One tablet containing Tamsulosin Hydrochloride 0.4 mg PR and Deflazacort 30 mg taken once daily.
  • Administration: Take the tablet approximately 30 minutes after the same meal each day to ensure consistent absorption.
  • Adjustments: Dosage adjustments may be necessary based on individual response and medical advice.

Side Effects

  • Common Side Effects:
  • Serious Side Effects:

Precautions

  • Medical History: Inform your doctor if you have a history of low blood pressure, liver disease, kidney disease, or diabetes.
  • Drug Interactions: Avoid using other alpha-blockers, blood pressure medications, or other corticosteroids without medical advice.
  • Surgical Considerations: If undergoing cataract surgery, inform your surgeon about using Tamsulosin due to the risk of Intraoperative Floppy Iris Syndrome (IFIS).

Benefits of Combination Therapy

  • Symptom Relief and Inflammation Control: The combination of Tamsulosin and Deflazacort not only relieves urinary symptoms but also manages inflammation effectively.
  • Improved Quality of Life: Patients experience significant improvements in both urinary and inflammatory symptoms, enhancing overall well-being.

Conclusion

TASMULINE DFZ, combining Tamsulosin Hydrochloride 0.4 mg PR and Deflazacort 30 mg, offers a comprehensive treatment option for BPH and inflammatory conditions. By addressing both urinary symptoms and inflammation, it provides effective relief and improves the quality of life. Always use this medication under medical supervision to ensure safety and efficacy.Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

 

 EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 

   BUY NOW

SHARE WITH